• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

子宫颈癌预防的成本效益

Cost-effectiveness of cervical cancer prevention.

作者信息

Esselen Katharine M, Feldman Sarah

机构信息

Brigham and Women's Hospital, Boston, Massachusetts, USA.

出版信息

Clin Obstet Gynecol. 2013 Mar;56(1):55-64. doi: 10.1097/GRF.0b013e3182823797.

DOI:10.1097/GRF.0b013e3182823797
PMID:23318570
Abstract

Cost-effectiveness analyses are an important tool for the evaluation and modification of many health care services. Given the variety of screening tests and treatments available for cervical cancer screening and prevention, the costs associated with these options and with their alternatives, and the differences in resources and settings in which these tests are applied worldwide, cost-effectiveness analyses evaluation can be very useful to help determine best practices.

摘要

成本效益分析是评估和改进许多医疗保健服务的重要工具。鉴于宫颈癌筛查和预防有多种筛查测试和治疗方法,这些选择及其替代方案的相关成本,以及在全球范围内应用这些测试的资源和环境差异,成本效益分析评估对于帮助确定最佳实践非常有用。

相似文献

1
Cost-effectiveness of cervical cancer prevention.子宫颈癌预防的成本效益
Clin Obstet Gynecol. 2013 Mar;56(1):55-64. doi: 10.1097/GRF.0b013e3182823797.
2
Cervical cancer screening in low- and middle-income countries.低收入和中等收入国家的宫颈癌筛查
Mt Sinai J Med. 2011 May-Jun;78(3):319-26. doi: 10.1002/msj.20263.
3
Cost effectiveness of prophylactic HPV 16/18 vaccination in Finland: results from a modelling exercise.芬兰预防性 HPV 16/18 疫苗接种的成本效益:模型研究结果。
J Med Econ. 2010;13(2):284-94. doi: 10.3111/13696998.2010.485951.
4
Projected cost-effectiveness of repeat high-risk human papillomavirus testing using self-collected vaginal samples in the Swedish cervical cancer screening program.基于自我采集阴道样本的重复高危型人乳头瘤病毒检测在瑞典宫颈癌筛查项目中的成本效果预测。
Acta Obstet Gynecol Scand. 2013 Jul;92(7):830-40. doi: 10.1111/aogs.12143. Epub 2013 Apr 22.
5
Modeling cost-effectiveness of cervical cancer screening in Hungary.匈牙利宫颈癌筛查成本效益建模。
Value Health. 2012 Jan;15(1):39-45. doi: 10.1016/j.jval.2011.10.003.
6
Cost-effectiveness analysis for Pap smear screening and human papillomavirus DNA testing and vaccination.巴氏涂片筛查、人乳头瘤病毒 DNA 检测与疫苗接种的成本效益分析。
J Eval Clin Pract. 2011 Dec;17(6):1050-8. doi: 10.1111/j.1365-2753.2010.01453.x. Epub 2011 Jun 16.
7
Cost-effectiveness analysis of HPV vaccination alongside cervical cancer screening programme in Slovenia.斯洛文尼亚 HPV 疫苗接种与宫颈癌筛查计划的成本效益分析。
Eur J Public Health. 2010 Aug;20(4):415-21. doi: 10.1093/eurpub/ckp208. Epub 2010 Jul 12.
8
A cost-utility analysis of adding a bivalent or quadrivalent HPV vaccine to the Irish cervical screening programme.对在爱尔兰宫颈筛查项目中增加二价或四价人乳头瘤病毒(HPV)疫苗的成本效用分析。
Eur J Public Health. 2010 Apr;20(2):213-9. doi: 10.1093/eurpub/ckp141. Epub 2009 Oct 28.
9
How to screen for cervical cancer after HPV16/18 vaccination in The Netherlands.在荷兰,人乳头瘤病毒16/18型疫苗接种后如何进行宫颈癌筛查。
Vaccine. 2009 Aug 13;27(37):5111-9. doi: 10.1016/j.vaccine.2009.06.043. Epub 2009 Jun 28.
10
Introducing HPV vaccine and scaling up screening procedures to prevent deaths from cervical cancer in Japan: a cost-effectiveness analysis.在日本引入 HPV 疫苗并扩大筛查程序以预防宫颈癌死亡:成本效益分析。
BJOG. 2012 Jan;119(2):177-86. doi: 10.1111/j.1471-0528.2011.03036.x. Epub 2011 Jul 28.

引用本文的文献

1
Willingness of adults in the United States to have a multicancer detection test.美国成年人进行多种癌症检测测试的意愿。
Cancer Causes Control. 2025 May 31. doi: 10.1007/s10552-025-02014-2.
2
Factors associated with the use of annual health checkups in Thailand: evidence from a national cross-sectional health and welfare survey.与泰国年度健康检查使用相关的因素:来自全国横断面健康和福利调查的证据。
Front Public Health. 2024 May 10;12:1390125. doi: 10.3389/fpubh.2024.1390125. eCollection 2024.
3
Non-use and inadequate use of cervical cancer screening among a representative sample of women in the United States.
美国代表性女性样本中宫颈癌筛查的未使用和使用不足。
Front Public Health. 2024 Apr 22;12:1321253. doi: 10.3389/fpubh.2024.1321253. eCollection 2024.
4
The role of sex and rurality in cancer fatalistic beliefs and cancer screening utilization in Florida.性别的作用和农村地区在佛罗里达州癌症宿命信念和癌症筛查利用中的作用。
Cancer Med. 2021 Sep;10(17):6048-6057. doi: 10.1002/cam4.4122. Epub 2021 Jul 13.
5
Simple but not simpler: a systematic review of Markov models for economic evaluation of cervical cancer screening.简单但非简易:宫颈癌筛查经济评估马尔可夫模型的系统评价
Clinics (Sao Paulo). 2018 Jul 10;73:e385. doi: 10.6061/clinics/2018/e385.
6
Systematic review of model-based cervical screening evaluations.基于模型的子宫颈癌筛查评估的系统评价
BMC Cancer. 2015 May 1;15:334. doi: 10.1186/s12885-015-1332-8.